Left ventricular non-compaction (LVNC) is the third most prevalent cardiomyopathy in children and its pathogenesis has been associated with the developmental defect of the embryonic myocardium. We ...
Since their discovery in 2006 by Takahashi and Yamanaka, induced pluripotent stem cells (iPSCs) have seen a remarkable surge in their application within academic and industrial research. Generated by ...
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that ...
Human induced pluripotent stem cells (iPSCs) provide a novel platform for developing cell therapies targeting diseases, from rare genetic disorders to cancer, autoimmune diseases and regenerative ...
Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...
A multi-institutional group, including members of the Tau Consortium, unveiled a stem cell tool kit for scientists studying primary tauopathies. In the November 12 issue of Stem Cell Reports, ...
TipRanks on MSN
Century Therapeutics announces resignation of board member
An announcement from Century Therapeutics ( ($IPSC) ) is now available. On December 18, 2025, Century Therapeutics, Inc. announced that board ...
IPSC was founded in 1977 and has grown rapidly over the past 30 years. With over 800 employees, IPSC is a multi-divisional firm. IPSC installs high quality security systems for residential and ...
SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...
Taiwan’s biotech industry is living its golden days, and LumiSTAR is certainly one of its shining examples. It all started at Oxford University, when LumiSTAR co-founders Yu-Fen Chang, CEO, and ...
Colossal scientists achieve global first; technology promises seminal advancements for engineering Woolly Mammoth phenotypes in in vitro cellular models, developmental biology, and attaining balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results